(RTTNews) - Biofrontera Inc. (BFRI) said the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application for Ameluz topical gel in combination with the RhodoLED red ...

Biofrontera Inc. announced that the last patient in its Phase 3 study, ALA-BCC-CT013, of Ameluz and RhodoLED PDT for treating superficial basal cell carcinoma (sBCC) completed their one-year follow-up ...

Red light photodynamic therapy (PDT) with 10% aminolevulinic acid (ALA) tamed superficial basal cell carcinoma (BCC) in a phase 3 trial with no new safety concerns. Significantly higher clearance ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ameluz is a topical currently indicated for the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Five years after treatment, results showed a freedom ...

ORLANDO, Fla. — Beyond appropriate use criteria for Mohs surgery outlined by a multidisciplinary ad hoc task force in 2012, choice of treatment for superficial skin cancers like basal cell carcinoma ...

Katlein Franca, MD, is a dermatologist and clinical associate professor of Dermatology & Cutaneous Surgery and Psychiatry & Behavioral Sciences at the University of Miami. Basal cell carcinoma often ...

Finger lesions are easy to dismiss, but some unusually persistent ones might need a closer look, according to doctors.

A rare case of basal cell carcinoma (BCC) on the right middle finger in a 63-year-old man underscores that this common skin ...